Among the main reasons for the development of MDR in cancer cells is the excessive efflux of drugs by pumps belonging to ATP-dependent transporters, which include breast cancer resistance protein (BCRP), P-glycoprotein (P-gp, MDR1), and multidrug resistance protein 1 (MRP1) [5,8]. Here, ABCG2 is linked to cancer.